Stereoselective synthesis of MaR2n-3 DPA

[1]  T. Hansen,et al.  Synthesis, Structural Confirmation, and Biosynthesis of 22-OH-PD1n-3 DPA † , 2019, Molecules.

[2]  C. Serhan,et al.  Resolving Inflammation: Synthesis, Configurational Assignment, and Biological Evaluations of RvD1n-3 DPA. , 2018, Chemistry.

[3]  C. Serhan,et al.  The Protectin Family of Specialized Pro-resolving Mediators: Potent Immunoresolvents Enabling Innovative Approaches to Target Obesity and Diabetes , 2019, Front. Pharmacol..

[4]  C. Serhan,et al.  Identification and structure elucidation of the pro‐resolving mediators provides novel leads for resolution pharmacology , 2018, British journal of pharmacology.

[5]  E. Aronica,et al.  n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis , 2018, Brain : a journal of neurology.

[6]  Charles N Serhan,et al.  Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. , 2018, Journal of Clinical Investigation.

[7]  T. Hansen,et al.  PDn-3 DPA Pathway Regulates Human Monocyte Differentiation and Macrophage Function , 2018, Cell Chemical Biology.

[8]  C. Serhan,et al.  Lipid Mediator Metabolomics Via LC-MS/MS Profiling and Analysis. , 2018, Methods in molecular biology.

[9]  J. Dalli.  Does promoting resolution instead of inhibiting inflammation represent the new paradigm in treating infections? , 2017, Molecular aspects of medicine.

[10]  C. Serhan,et al.  Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. , 2017, Molecular aspects of medicine.

[11]  T. Hansen,et al.  Stereocontrolled synthesis and investigation of the biosynthetic transformations of 16(S),17(S)-epoxy-PDn-3 DPA. , 2017, Organic & biomolecular chemistry.

[12]  C. Serhan,et al.  The novel lipid mediator PD1n-3 DPA: An overview of the structural elucidation, synthesis, biosynthesis and bioactions. , 2017, Prostaglandins & other lipid mediators.

[13]  T. Hansen,et al.  Recent advances in the chemistry and biology of anti-inflammatory and specialized pro-resolving mediators biosynthesized from n-3 docosapentaenoic acid. , 2017, Bioorganic & medicinal chemistry letters.

[14]  C. Serhan.  Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  M. Perretti,et al.  Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection , 2017, Proceedings of the National Academy of Sciences.

[16]  Derek W. Gilroy,et al.  Resolution of inflammation: a new therapeutic frontier , 2016, Nature Reviews Drug Discovery.

[17]  M. Aursnes,et al.  An efficient total synthesis of leukotriene B4. , 2015, Organic & biomolecular chemistry.

[18]  M. Aursnes,et al.  Stereoselective synthesis of maresin 1 , 2015 .

[19]  B. Spur,et al.  First total synthesis of the macrophage derived anti-inflammatory and pro-resolving lipid mediator Maresin 2 , 2015 .

[20]  C. Serhan,et al.  Total synthesis of the anti-inflammatory and pro-resolving lipid mediator MaR1n-3 DPA utilizing an sp(3) -sp(3) Negishi cross-coupling reaction. , 2014, Chemistry.

[21]  B. Spur,et al.  Total synthesis of the potent anti-inflammatory lipid mediator Protectin D1 , 2014 .

[22]  Charles N. Serhan,et al.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[23]  Yuichi Kobayashi,et al.  Synthesis of maresin 1 and (7S)-isomer , 2014 .

[24]  C. Serhan,et al.  Total Synthesis of the Lipid Mediator PD1n-3 DPA: Configurational Assignments and Anti-inflammatory and Pro-resolving Actions , 2014, Journal of natural products.

[25]  C. Serhan,et al.  Resolution phase lipid mediators of inflammation: agonists of resolution. , 2013, Current opinion in pharmacology.

[26]  J. Haeggström,et al.  The novel 13S,14S ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  C. Serhan,et al.  Novel n-3 Immunoresolvents: Structures and Actions , 2013, Scientific Reports.

[28]  Ira Tabas,et al.  Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities , 2013, Science.

[29]  Min-Jia Zhu.  Total Synthesis of Specialized Pro-resolving Lipid Mediators and Their Analogs , 2013 .

[30]  T. Hansen,et al.  Concise syntheses of three ω-3 polyunsaturated fatty acids , 2012 .

[31]  C. Serhan,et al.  Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. , 2012, Blood.

[32]  B. Spur,et al.  Total synthesis of the macrophage derived anti-inflammatory lipid mediator Maresin 1 , 2012 .

[33]  C. Serhan,et al.  Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  C. Serhan,et al.  Resolvins and protectins in inflammation resolution. , 2011, Chemical reviews.

[35]  M. Arita,et al.  Total synthesis and bioactivities of two proposed structures of maresin. , 2011, Chemistry, an Asian journal.

[36]  M. Garg,et al.  Docosapentaenoic acid (22:5n-3): a review of its biological effects. , 2011, Progress in lipid research.

[37]  C. Serhan,et al.  Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions , 2009, The Journal of experimental medicine.

[38]  B. Spur,et al.  First total synthesis of 7(S),16(R),17(S)-Resolvin D2, a potent anti-inflammatory lipid mediator , 2004 .

[39]  Adriano G. Rossi,et al.  Inflammatory Resolution: new opportunities for drug discovery , 2004, Nature Reviews Drug Discovery.

[40]  B. Spur,et al.  Total synthesis of aspirin-triggered 15-epi-lipoxin A4 , 2001 .